Adam J. Luginbuhl

Adam J. Luginbuhl is a surgical oncologist at the Sidney Kimmel Comprehensive Cancer Center, specializing in immunotherapy for head and neck cancer. Jennifer M. Johnson, also from the same center, focuses on treating advanced cases with immunotherapy. They delve into the impact of neoadjuvant nivolumab on HPV-negative head and neck squamous cell carcinoma, discussing patient outcomes and the critical role of early treatment responses. The conversation highlights the evolving dynamics in tumor boards and the importance of personalized care in enhancing patient survival.